MLAB News and Press, Mesa Laboratories Inc. From 06/09/20

Source : Mesa Laboratories, Inc. - June 9, 2020 8:15 PM ET Lakewood, Colo., June 09, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced the pricing of an underwritten public offering of 600,000 shares of its common stock at a pub...

Mesa Laboratories (NASDAQ: MLAB ) down  1.2%  in AH as the company announces public offering of $100M, and underwriters have an option to purchase up to an additional $15M of shares. More news on: Mesa Laboratories, Inc., Healthcare stocks news, , Read more ...

Source: Mesa Laboratories, Inc. – June 8, 2020 4:01 PM ET LAKEWOOD, Colo., June 08, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa Labs”) today announced that it has commenced an underwritten public offering of $100 million of shares o...

Mesa Laboratories (NASDAQ: MLAB ): Q4 GAAP EPS of -$0.37 misses by $1.04 . Revenue of $34.21M (+29.3% Y/Y) misses by $0.28M . Press Release More news on: Mesa Laboratories, Inc., Earnings news and commentary, Healthcare stocks news,

LAKEWOOD, Colo., June 01, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q20”) and full year ended March 31, 2020 (“FY20”). Financial highlights for the quarter and year ended March 31, 2020 as...

LAKEWOOD, Colo., May 15, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced the election of Shannon Hall to its Board of Directors.  Shannon previously led the Life Sciences business at Bio-Rad Laboratories. Ms. Hall’s election fills the open posit...

Mesa Laboratories (NASDAQ: MLAB ) declares $0.16/share quarterly dividend , in line with previous. Forward yield 0.28% Payable June 15; for shareholders of record May 29; ex-div May 28. See MLAB Dividend Scorecard, Yield Chart, & Dividend Growth. More news on: Mesa Laborato...

Gyros Protein Technologies AB, a Mesa Laboratories, Inc. (NASDAQ:MLAB) company, and pioneer in automated nanoliter-scale immunoassays and leading provider of peptide synthesizers and reagents, and the Jefferson Institute for Bioprocessing (JIB) at Thomas Jefferson University, a leading center...

Investors interested in the long-term life sciences market should be interested in how to invest in medical devices, as they continue to play a prominent role in every level of healthcare. This market covers a wide range of health and medical instruments used in the treatment, mitigation, ...

Mesa Laboratories (NASDAQ: MLAB ): Q3 GAAP EPS of -$1.06 misses by $1.94 . Revenue of $31.66M (+18.7% Y/Y) beats by $0.32M . Press Release More news on: Mesa Laboratories, Inc., Earnings news and commentary, Healthcare stocks news,